Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 14, 2017; 23(2): 265-274
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.265
Table 1 Clinicopathologic characteristics of 52 patients undergoing total pancreatectomy
VariableNo. of patients
Mean age ± SD (yr)60.3 ± 9.0
Sex (male)32
Pathology
Adenocarcinoma43
Cystadenocarcinoma2
Invasive IPMN4
Acinar adenocarcinoma1
Adenosquamous carcinoma1
Renal cell carcinoma metastasis1
Tumor location
Head28
Corpus15
Tail3
> 1 location6
Median primary tumor size (IQR) (cm)4.7 (3.0-6.0)
Venous invasion26
Lymph node invasion18
Splenectomy11
Operative time (IQR) (min)472.5 (421.3-548.8)
Operative arrangement
Planned20
Unplanned32
Postoperative complication1
Gastroplegia4
Gastrointestinal or abdominal hemorrhage bleeding1
Pneumonia14
Abdominal infection9
Hepatic failure1
Respiratory failure1
Length of postoperative hospital stay (IQR) (d)12.0 (10.0-17.8)
Neoadjuvant treatment14
Adjuvant treatment52
Median recurrence-free time (IQR) (mo)4.7 (2.7-13.6)
Median survival time (IQR) (mo)20.9 (10.2-51.0)
1-year survival (%)63.4
3-year survival (%)24.2
5-year survival (%)12.5
Table 2 Changes in biochemical data after total pancreatectomy
PreopPostop1Postop 1 moPostop 3 moPostop 6 moPostop 12 moP value2
FBG (mg/dL)130 ± 60154 ± 39153 ± 84167 ± 94149 ± 68142 ± 790.078
HbA1c (%)6.7 ± 1.5/6.7 ± 0.87.2 ± 1.06.8 ± 0.86.5 ± 0.80.330
BMI (kg/m2)22.3 ± 3.2/21.2 ± 3.020.6 ± 2.820.3 ± 3.019.6 ± 2.50.001
Total protein (g/L)65.7 ± 9.260.4 ± 6.668.4 ± 5.866.4 ± 4.967.2 ± 8.567.8 ± 6.30.369
Albumin (g/L)39.3 ± 4.038.0 ± 4.238.2 ± 4.036.2 ± 4.438.0 ± 7.738.8 ± 4.60.933
Prealbumin (mg/L)203.9 ± 54.3171.6 ± 40.8135.3 ± 34.6147.9 ± 42.0145.9 ± 48.8148.2 ± 54.60.001
PNI46.0 ± 3.447.8 ± 6.344.6 ± 4.043.8 ± 5.942.7 ± 5.947.3 ± 4.80.244
Table 3 Factors for complications, recurrence-free and overall survival after total pancreatectomy
VariableMultivariate analysis
Odds ratio/hazard ratio95%CIP value
Complications
Postop FBG1
< 155 mg/dL
≥ 155 mg/dL4.0741.188-13.9650.025
Postop prealbumin1
> 185 mg/L
≤ 185 mg/L3.8161.110-13.1220.034
Recurrence-free survival
Preop FBG
≤ 110 mg/dL
> 110 mg/dL2.3301.204-4.5100.012
Venous invasion
No
Yes2.9751.502-5.8920.002
Postop HbA1c1
< 7%
≥ 7%2.6551.299-5.4250.007
Postop PNI1
> 45
≤ 451.7600.897-3.4550.100
Overall survival
Diabetes mellitus
No
Short-term0.9430.300-2.9650.920
Long-term2.3050.560-9.4830.247
Preop FBG
≤ 110 mg/dL
> 110 mg/dL1.1120.357-3.4620.854
Postop HbA1c2
< 7%
≥ 7%3.2121.147-8.9990.026
Postop total protein2
> 55 g/L
≤ 55 g/L1.1520.304-4.3640.835
Postop albumin2
> 35 g/L
≤ 35 g/L2.8940.551-15.1950.209
Postop prealbumin2
> 185 mg/L
≤ 185 mg/L3.9610.976-16.0680.054
Postop PNI2
> 45
≤ 451.1430.242-5.4080.866
Table 4 Preoperative factors for postoperative glycemic control and changes in body mass index after total pancreatectomy
VariableMultivariate analysis
Odds ratio/B95%CI/SEP value
Postoperative glycemic control1
Diabetes mellitus
No
Short-term0.7600.187-3.0970.702
Long-term15.0191.278-176.2110.031
Preop HbA1c
< 6.5%1
≥ 6.5%1.5660.293-8.3750.600
Changes in BMI1
Age (yr)-1.0100.7330.175
Alcohol history, yes or no1.9850.8600.025